{"id":"W2036186700","doi":"10.1136/gut.2005.089854","title":"Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial","year":2006,"lang":"en","type":"article","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; McGill University; University of British Columbia; Vancouver General Hospital; Western University","funders":"Generalitat Valenciana","keywords":"Daclizumab; Monoclonal antibody; Medicine; Ulcerative colitis; Placebo; Double blind; Monoclonal; Vedolizumab; Receptor; Internal medicine; Pharmacology; Immunology; Gastroenterology; Antibody; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000351743,0.0003044071,0.00043139,0.00006251798,0.0003121399,0.00008715272,0.0002813126,0.0001145016,0.00004569642],"category_scores_gemma":[0.00008703975,0.0001872512,0.0004279125,0.00008005805,0.00007472708,0.000009016275,0.00005517908,0.00006005695,0.00002179283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001115198,"about_ca_system_score_gemma":0.0002549469,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001243302,"about_ca_topic_score_gemma":0.0007310428,"domain_scores_codex":[0.9983233,0.0002118208,0.0004715403,0.0004294048,0.0001893521,0.000374609],"domain_scores_gemma":[0.9988434,0.0001973746,0.0001916816,0.0004283801,0.0002333128,0.000105836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9774705,0.0003166937,0.000003981412,0.000009328921,0.0005002783,0.000007571147,0.0009343905,0.003285093,0.01432696,0.0002807525,0.002278799,0.0005856348],"study_design_scores_gemma":[0.9242901,0.002313809,0.001408326,0.00002862214,0.0003153548,0.000004251444,0.0005349761,0.00138591,0.04928495,0.00007219812,0.01998577,0.0003758016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821907,0.0001194399,0.003320664,0.0003825808,0.0003495043,0.01250624,0.0003756836,0.00001541228,0.0007398099],"genre_scores_gemma":[0.9906622,0.00002193749,0.0002944635,0.0002470583,0.0009117867,0.005370857,0.0002623372,0.00004020331,0.002189171],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05318047,"threshold_uncertainty_score":0.7635881,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02153205195749857,"score_gpt":0.3038684070177876,"score_spread":0.282336355060289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}